Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Muhonen

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Melanoma Research|July 17, 1998
Prognostic value of biomarkers in malignant melanomaM Hernberg, J P Turunen, K von Boguslawsky, et al.
Histopathology|October 8, 2004
Tenascin-C in primary malignant melanoma of the skinS Ilmonen, T Jahkola, J P Turunen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Unexpected prolonged myelosuppression after mitomycin, mitoxantrone and methotrexateT T Muhonen, T A Wiklund, C P Blomqvist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapyM Hernberg, T Muhonen, J P Turunen, et al.
Nature Communications|July 8, 2017
Nonlinear cavity optomechanics with nanomechanical thermal fluctuationsRick Leijssen, Giada R La Gala, Lars Freisem, et al.
The British Journal of Dermatology|June 1, 1995
Response of subcutaneous and cutaneous metastases of malignant melanoma to combined cytostatic plus interferon therapyM Hahka-Kemppinen, T Muhonen, M Virolainen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomised studyI T Jantunen, T T Muhonen, V V Kataja, et al.
Melanoma Research|August 28, 1999
Prognostic value of tumour vascularity in primary melanomaS Ilmonen, A L Kariniemi, T Vlaykova, et al.
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|August 8, 2002
Prognosis of primary melanomaS Ilmonen, S Asko-Seljavaara, A L Kariniemi, et al.
Melanoma Research|May 25, 1999
Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expressionT Vlaykova, P Laurila, T Muhonen, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Melanoma Research|July 17, 1998
Prognostic value of biomarkers in malignant melanomaM Hernberg, J P Turunen, K von Boguslawsky, et al.
Histopathology|October 8, 2004
Tenascin-C in primary malignant melanoma of the skinS Ilmonen, T Jahkola, J P Turunen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Unexpected prolonged myelosuppression after mitomycin, mitoxantrone and methotrexateT T Muhonen, T A Wiklund, C P Blomqvist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapyM Hernberg, T Muhonen, J P Turunen, et al.
Nature Communications|July 8, 2017
Nonlinear cavity optomechanics with nanomechanical thermal fluctuationsRick Leijssen, Giada R La Gala, Lars Freisem, et al.
The British Journal of Dermatology|June 1, 1995
Response of subcutaneous and cutaneous metastases of malignant melanoma to combined cytostatic plus interferon therapyM Hahka-Kemppinen, T Muhonen, M Virolainen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomised studyI T Jantunen, T T Muhonen, V V Kataja, et al.
Melanoma Research|August 28, 1999
Prognostic value of tumour vascularity in primary melanomaS Ilmonen, A L Kariniemi, T Vlaykova, et al.
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|August 8, 2002
Prognosis of primary melanomaS Ilmonen, S Asko-Seljavaara, A L Kariniemi, et al.
Melanoma Research|May 25, 1999
Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expressionT Vlaykova, P Laurila, T Muhonen, et al.
Pageof 6